SCHEMBL5436667

SCHEMBL5436667

COc1cc(-c2c(-c3ccccc3)noc2C)ccc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ L3MBTL1 Q9Y468 3/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ ATM Q13315 1/20 0.53
▸ PTGS2 P35354 6/20 0.52
▸ PTGS1 P23219 3/20 0.52
▸ GAA P10253 2/20 0.52
▸ MKNK1 Q9BUB5 1/20 0.52
▸ MKNK2 Q9HBH9 1/20 0.52
▸ PAX8 Q06710 1/20 0.51
▸ MT-CO2 P00403 3/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ CA3 P07451 1/20 0.50
▸ ADRB2 P07550 1/20 0.50
▸ ADRB1 P08588 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14562082 0.91 KMT2A (0.53) KMT2AMEN1L3MBTL1NPC1ATM
SCHEMBL16493575 0.88 NPC1 (0.51) KMT2AMEN1L3MBTL1NPC1ATM
SCHEMBL14562104 0.85 PTGS2 (0.57) KMT2AMEN1NPC1PTGS2PTGS1
SCHEMBL14562090 0.85 PTGS2 (0.64) KMT2AMEN1L3MBTL1NPC1PTGS2
SCHEMBL5420970 0.84 PTGS2 (0.56) KMT2AMEN1NPC1PTGS2PTGS1
SCHEMBL14562177 0.82 PTGS2 (0.59) KMT2AMEN1PTGS2PTGS1GAA
SCHEMBL14562119 0.80 GABRA5 (0.50) KMT2AMEN1L3MBTL1NPC1ATM
SCHEMBL14562102 0.78 PTGS2 (0.60) KMT2AMEN1PTGS2PTGS1GAA
SCHEMBL5417981 0.77 PTGS2 (0.56) KMT2AMEN1L3MBTL1NPC1ATM
SCHEMBL14562174 0.77 PTGS2 (0.52) KMT2AMEN1L3MBTL1NPC1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060629-A1 Large conductance calcium-activated k channel opener TANABE SEIYAKU CO., LTD. (JP) 2007-03-15 — — US disclosed
US-20070060629-A1 Large conductance calcium-activated k channel opener TANABE SEIYAKU CO., LTD. (JP) 2007-03-15 — — US disclosed
US-20070060629-A1 Large conductance calcium-activated k channel opener TANABE SEIYAKU CO., LTD. (JP) 2007-03-15 — — US disclosed
EP-1675585-A2 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER TANABE SEIYAKU CO., LTD. (JP) 2006-07-05 — — EP disclosed
WO-2005037271-A2 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER TANABE SEIYAKU CO., LTD. (JP) 2005-04-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060629-A1 Large conductance calcium-activated k channel opener KCNN3, KCNN1, KCNN2 KMT2A 1235/4885MEN1 2167/4885L3MBTL1 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback